Docetaxel neuropathy

被引：9

作者：

Apfel, SC ^{[1
]}

机构：

[1] ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10467

来源：

NEUROLOGY | 1996年 / 46卷 / 01期

关键词：

D O I：

10.1212/WNL.46.1.2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2 / 3

页数：2

共 24 条

[1]

AAPRO M, 1993, P AN M AM SOC CLIN, V12, P256

[2] NERVE GROWTH-FACTOR PREVENTS TOXIC NEUROPATHY IN MICE [J].

APFEL, SC ;

LIPTON, RB ;

AREZZO, JC ;

KESSLER, JA .

ANNALS OF NEUROLOGY, 1991, 29 (01) :87-90

[3] NERVE GROWTH-FACTOR PREVENTS EXPERIMENTAL CISPLATIN NEUROPATHY [J].

APFEL, SC ;

AREZZO, JC ;

LIPSON, L ;

KESSLER, JA .

ANNALS OF NEUROLOGY, 1992, 31 (01) :76-80

[4]

APFEL SC, 1993, ANN NY ACAD SCI, V692, P243

[5] CYTARABINE AND NEUROLOGIC TOXICITY [J].

BAKER, WJ ;

ROYER, GL ;

WEISS, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :679-693

[6]

BISSERY MC, 1991, CANCER RES, V51, P4845

[7] 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (D4T) IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX - A PHASE-I TRIAL [J].

BROWNE, MJ ;

MAYER, KH ;

CHAFEE, SBD ;

DUDLEY, MN ;

POSNER, MR ;

STEINBERG, SM ;

GRAHAM, KK ;

GELETKO, SM ;

ZINNER, SH ;

DENMAN, SL ;

DUNKLE, LM ;

KAUL, S ;

MCLAREN, C ;

SKOWRON, G ;

KOUTTAB, NM ;

KENNEDY, TA ;

WEITBERG, AB ;

CURT, GA .

JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :21-29

[8] PHASE-I CLINICAL-TRIAL WITH CARBETIMER [J].

DODION, P ;

DEVALERIOLA, D ;

BODY, JJ ;

HOUA, M ;

NOEL, P ;

ABRAMS, J ;

CRESPEIGNE, N ;

WERY, F ;

KENIS, Y .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :279-&

[9]

Gao W.-Q., 1994, Society for Neuroscience Abstracts, V20, P442

[10] THE TAXOIDS - PACLITAXEL AND DOCETAXEL [J].

GELMON, K .

LANCET, 1994, 344 (8932) :1267-1272

← 1 2 3 →